BEAM THERAPEUTICS INC (BEAM) Stock Analyst Ratings
NASDAQ:BEAM • US07373V1052
28.13 USD
+0.54 (+1.96%)
Last: Feb 23, 2026, 01:52 PM
ChartMill assigns a Buy % Consensus number of 87% to BEAM. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 47.45. This target is 68.68% above the current price.
- BEAM was analyzed by 24 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about BEAM.
- In the previous month the buy percentage consensus was at a similar level.
- BEAM was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-20 | Canaccord Genuity | Initiate | Buy |
| 2026-01-21 | Bernstein | Maintains | Outperform -> Outperform |
| 2026-01-07 | UBS | Initiate | Neutral |
| 2025-11-24 | Evercore ISI Group | Initiate | Outperform |
| 2025-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-03-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-10 | Jones Trading | Upgrade | Hold -> Buy |
| 2025-03-10 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-27 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-26 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-29 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2024-12-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-06 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-11-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-16 | ScotiaBank | Initiate | Sector Perform |
| 2024-09-19 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-09-17 | Jones Trading | Initiate | Hold |
| 2024-09-11 | Stifel | Maintains | Buy -> Buy |
BEAM THERAPEUTICS INC / BEAM FAQ
What is the average price target for BEAM THERAPEUTICS INC (BEAM) stock?
24 analysts have analysed BEAM and the average price target is 47.45 USD. This implies a price increase of 68.68% is expected in the next year compared to the current price of 28.13.
Can you provide the consensus rating for BEAM THERAPEUTICS INC stock?
The consensus rating for BEAM THERAPEUTICS INC (BEAM) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BEAM stock?
The number of analysts covering BEAM THERAPEUTICS INC (BEAM) is 24.